Keros Therapeutics

KROS

NASDAQHealth Care

Income Statement

Total Revenue$3.55M

Gross Profit$3.55M

Operating Income$-210.83M

EBITDA$-184M

EBIT$-187.05M

Pre-tax Income$91.9M

Net Income$-187.35M

Cash Equivalent$486.06M

Total Debt$16.58M

Book Value$494.81M

Book Value Per Share13.19

Return on Equity (ROE)-32.78%

Return on Assets (ROA)-30.42%

Return on Invested Capital (ROI)-32.78%

Net Profit Margin-5277.55%

Current Ratio21.45

Quick Ratio20.61

Long-Term Debt / Equity0.00